Lyme	B-KP	0,4
disease	I-KP	5,12
(LD)	B-KP	14,18
is	O	19,21
a	O	22,23
tick-borne	O	24,34
infection	O	35,44
caused	O	45,51
by	O	52,54
the	O	55,58
spirochete	I-KP	59,69
Borrelia	I-KP	70,78
burgdorferi.	O	79,91

Primary	O	92,99
LD	I-KP	100,102
commonly	O	103,111
presents	O	112,120
as	O	121,123
a	O	124,125
flu-like	O	126,134
ifiness	O	135,142
in	O	143,145
children,	O	146,155
sometimes	O	156,165
accompanied	O	166,177
by	O	178,180
the	O	181,184
diagnostic	O	185,195
rash	O	196,200
known	O	201,206
as	O	207,209
erythema	I-KP	210,218
migrans	I-KP	219,226
(EM).	B-KP	227,232

[1]	O	233,236
Rheumatologic,	O	237,251
neurologic,	O	252,263
dermatologic,	O	264,277
or	O	278,280
cardiologic	I-KP	281,292
manifestations	O	293,307
in	O	308,310
systemic	O	311,319
LD	I-KP	320,322
may	O	323,326
follow	O	327,333
the	O	334,337
primary	O	338,345
infection	O	346,355
by	O	356,358
weeks	O	359,364
or	O	365,367
months,	O	368,375
or	O	376,378
they	O	379,383
may	O	384,387
be	O	388,390
the	O	391,394
initial	O	395,402
presentation	O	403,415
of	O	416,418
LD.	O	419,422

A	O	423,424
wide	O	425,429
variety	O	430,437
of	O	438,440
neurologic	I-KP	441,451
syndromes	I-KP	452,461
have	O	462,466
been	O	467,471
reported	O	472,480
in	O	481,483
both	O	484,488
children	O	489,497
and	O	498,501
adults	O	502,508
with	O	509,513
LD,	O	514,517
ranging	O	518,525
from	O	526,530
acute	I-KP	531,536
myositis	I-KP	537,545
to	O	546,548
chronic	I-KP	549,556
encephalopathy.	O	557,572

However,	O	573,581
facial	I-KP	582,588
palsy	I-KP	589,594
and	O	595,598
aseptic	I-KP	599,606
meningitis	I-KP	607,617
are	O	618,621
the	O	622,625
most	O	626,630
commonly	O	631,639
reported	O	640,648
neurologic	O	649,659
manifestations.	O	660,675

[2]\nThe	O	676,684
nonspecificity	O	685,699
of	O	700,702
clinical	O	703,711
presentations	O	712,725
and	O	726,729
limitations	O	730,741
in	O	742,744
laboratory	O	745,755
diagnosis	O	756,765
complicate	O	766,776
the	O	777,780
diagnosis	O	781,790
of	O	791,793
neuroborreliosis.	O	794,811

While	O	812,817
Lyme	I-KP	818,822
serology	I-KP	823,831
is	O	832,834
considered	O	835,845
highly	O	846,852
sensitive	O	853,862
in	O	863,865
systemic	I-KP	866,874
LD,	O	875,878
false	O	879,884
positives	O	885,894
may	O	895,898
be	O	899,901
due	O	902,905
to	O	906,908
asymptomatic	I-KP	909,921
seroconversion,	O	922,937
antibodies	O	938,948
to	O	949,951
oral	I-KP	952,956
spirochetes,	O	957,969
prior	O	970,975
infection,	O	976,986
or	O	987,989
immunologic	O	990,1001
cross	O	1002,1007
reaction	O	1008,1016
to	O	1017,1019
other	O	1020,1025
pathogens.	O	1026,1036

Several	O	1037,1044
authors	O	1045,1052
have	O	1053,1057
emphasized	O	1058,1068
the	O	1069,1072
precedence	O	1073,1083
of	O	1084,1086
clinical	O	1087,1095
criteria	O	1096,1104
for	O	1105,1108
making	O	1109,1115
diagnostic	O	1116,1126
and	O	1127,1130
treatment	O	1131,1140
decisions	O	1141,1150
in	O	1151,1153
patients	O	1154,1162
with	O	1163,1167
suspected	O	1168,1177
LD.	O	1178,1181

[3-5]	O	1182,1187
When	O	1188,1192
new	O	1193,1196
neurologic	O	1197,1207
symptoms	O	1208,1216
appear	O	1217,1223
in	O	1224,1226
concert	O	1227,1234
with	O	1235,1239
other	O	1240,1245
clinical	O	1246,1254
manifestations	O	1255,1269
typical	O	1270,1277
of	O	1278,1280
LD,	O	1281,1284
the	O	1285,1288
diagnosis	O	1289,1298
of	O	1299,1301
neuroborreliosis	I-KP	1302,1318
is	O	1319,1321
usually	O	1322,1329
secure.\nBecause	O	1330,1346
individuals	O	1347,1358
with	O	1359,1363
systemic	O	1364,1372
signs	O	1373,1378
of	O	1379,1381
LD	I-KP	1382,1384
are	O	1385,1388
usually	O	1389,1396
seropositive,	O	1397,1410
we	O	1411,1413
reviewed	O	1414,1422
clinical	O	1423,1431
data	O	1432,1436
in	O	1437,1439
seropositive	I-KP	1440,1452
children	O	1453,1461
to	O	1462,1464
determine	O	1465,1474
1)	O	1475,1477
how	O	1478,1481
often	O	1482,1487
the	O	1488,1491
initial	O	1492,1499
clinical	O	1500,1508
evaluation	O	1509,1519
permitted	O	1520,1529
a	O	1530,1531
diagnosis	O	1532,1541
of	O	1542,1544
neuroborreliosis,	O	1545,1562
and	O	1563,1566
2)	O	1567,1569
the	O	1570,1573
range	O	1574,1579
of	O	1580,1582
neurologic	O	1583,1593
signs	O	1594,1599
in	O	1600,1602
children	O	1603,1611
with	O	1612,1616
positive	O	1617,1625
Lyme	I-KP	1626,1630
serology.	O	1631,1640

Lyme	B-KP	0,4
disease	I-KP	5,12
(LD)	B-KP	14,18
is	O	19,21
a	O	22,23
tick-borne	O	24,34
infection	O	35,44
caused	O	45,51
by	O	52,54
the	O	55,58
spirochete	I-KP	59,69
Borrelia	I-KP	70,78
burgdorferi.	O	79,91

Primary	O	92,99
LD	I-KP	100,102
commonly	O	103,111
presents	O	112,120
as	O	121,123
a	O	124,125
flu-like	O	126,134
ifiness	O	135,142
in	O	143,145
children,	O	146,155
sometimes	O	156,165
accompanied	O	166,177
by	O	178,180
the	O	181,184
diagnostic	O	185,195
rash	O	196,200
known	O	201,206
as	O	207,209
erythema	I-KP	210,218
migrans	I-KP	219,226
(EM).	B-KP	227,232

[1]	O	233,236
Rheumatologic,	O	237,251
neurologic,	O	252,263
dermatologic,	O	264,277
or	O	278,280
cardiologic	I-KP	281,292
manifestations	O	293,307
in	O	308,310
systemic	O	311,319
LD	I-KP	320,322
may	O	323,326
follow	O	327,333
the	O	334,337
primary	O	338,345
infection	O	346,355
by	O	356,358
weeks	O	359,364
or	O	365,367
months,	O	368,375
or	O	376,378
they	O	379,383
may	O	384,387
be	O	388,390
the	O	391,394
initial	O	395,402
presentation	O	403,415
of	O	416,418
LD.	O	419,422

A	O	423,424
wide	O	425,429
variety	O	430,437
of	O	438,440
neurologic	I-KP	441,451
syndromes	I-KP	452,461
have	O	462,466
been	O	467,471
reported	O	472,480
in	O	481,483
both	O	484,488
children	O	489,497
and	O	498,501
adults	O	502,508
with	O	509,513
LD,	O	514,517
ranging	O	518,525
from	O	526,530
acute	I-KP	531,536
myositis	I-KP	537,545
to	O	546,548
chronic	I-KP	549,556
encephalopathy.	O	557,572

However,	O	573,581
facial	I-KP	582,588
palsy	I-KP	589,594
and	O	595,598
aseptic	I-KP	599,606
meningitis	I-KP	607,617
are	O	618,621
the	O	622,625
most	O	626,630
commonly	O	631,639
reported	O	640,648
neurologic	O	649,659
manifestations.	O	660,675

[2]\nThe	O	676,684
nonspecificity	O	685,699
of	O	700,702
clinical	O	703,711
presentations	O	712,725
and	O	726,729
limitations	O	730,741
in	O	742,744
laboratory	O	745,755
diagnosis	O	756,765
complicate	O	766,776
the	O	777,780
diagnosis	O	781,790
of	O	791,793
neuroborreliosis.	O	794,811

While	O	812,817
Lyme	I-KP	818,822
serology	I-KP	823,831
is	O	832,834
considered	O	835,845
highly	O	846,852
sensitive	O	853,862
in	O	863,865
systemic	I-KP	866,874
LD,	O	875,878
false	O	879,884
positives	O	885,894
may	O	895,898
be	O	899,901
due	O	902,905
to	O	906,908
asymptomatic	I-KP	909,921
seroconversion,	O	922,937
antibodies	O	938,948
to	O	949,951
oral	I-KP	952,956
spirochetes,	O	957,969
prior	O	970,975
infection,	O	976,986
or	O	987,989
immunologic	O	990,1001
cross	O	1002,1007
reaction	O	1008,1016
to	O	1017,1019
other	O	1020,1025
pathogens.	O	1026,1036

Several	O	1037,1044
authors	O	1045,1052
have	O	1053,1057
emphasized	O	1058,1068
the	O	1069,1072
precedence	O	1073,1083
of	O	1084,1086
clinical	O	1087,1095
criteria	O	1096,1104
for	O	1105,1108
making	O	1109,1115
diagnostic	O	1116,1126
and	O	1127,1130
treatment	O	1131,1140
decisions	O	1141,1150
in	O	1151,1153
patients	O	1154,1162
with	O	1163,1167
suspected	O	1168,1177
LD.	O	1178,1181

[3-5]	O	1182,1187
When	O	1188,1192
new	O	1193,1196
neurologic	O	1197,1207
symptoms	O	1208,1216
appear	O	1217,1223
in	O	1224,1226
concert	O	1227,1234
with	O	1235,1239
other	O	1240,1245
clinical	O	1246,1254
manifestations	O	1255,1269
typical	O	1270,1277
of	O	1278,1280
LD,	O	1281,1284
the	O	1285,1288
diagnosis	O	1289,1298
of	O	1299,1301
neuroborreliosis	I-KP	1302,1318
is	O	1319,1321
usually	O	1322,1329
secure.\nBecause	O	1330,1346
individuals	O	1347,1358
with	O	1359,1363
systemic	O	1364,1372
signs	O	1373,1378
of	O	1379,1381
LD	I-KP	1382,1384
are	O	1385,1388
usually	O	1389,1396
seropositive,	O	1397,1410
we	O	1411,1413
reviewed	O	1414,1422
clinical	O	1423,1431
data	O	1432,1436
in	O	1437,1439
seropositive	I-KP	1440,1452
children	O	1453,1461
to	O	1462,1464
determine	O	1465,1474
1)	O	1475,1477
how	O	1478,1481
often	O	1482,1487
the	O	1488,1491
initial	O	1492,1499
clinical	O	1500,1508
evaluation	O	1509,1519
permitted	O	1520,1529
a	O	1530,1531
diagnosis	O	1532,1541
of	O	1542,1544
neuroborreliosis,	O	1545,1562
and	O	1563,1566
2)	O	1567,1569
the	O	1570,1573
range	O	1574,1579
of	O	1580,1582
neurologic	O	1583,1593
signs	O	1594,1599
in	O	1600,1602
children	O	1603,1611
with	O	1612,1616
positive	O	1617,1625
Lyme	I-KP	1626,1630
serology.	O	1631,1640

